Recombinant Human NPEPPS/PSA, N-His from ProteoGenix; catalogue ARO-P13614; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Title: Introduction to Recombinant Human NPEPPS/PSA
Recombinant Human NPEPPS/PSA, also known as NPEPPS or PSA, is a protein that plays an important role in various biological processes. It is a type II transmembrane protein that is expressed in various tissues, including the prostate, kidney, and brain. In this article, we will explore the structure, activity, and applications of this important protein.
Title: Structure of Recombinant Human NPEPPS/PSA
The NPEPPS/PSA protein is composed of 541 amino acids and has a molecular weight of approximately 60 kDa. It is made up of three domains: an N-terminal domain, a transmembrane domain, and a C-terminal domain. The N-terminal domain contains a zinc-binding motif, while the C-terminal domain contains a peptidase M16 domain, indicating its role as a metalloprotease.
Title: Activity of Recombinant Human NPEPPS/PSA
NPEPPS/PSA is a metalloprotease that is involved in the degradation of peptide hormones and neuropeptides. It cleaves these peptides at specific amino acid sequences, resulting in their inactivation. In addition, NPEPPS/PSA has been shown to play a role in the processing of amyloid precursor protein, which is involved in the development of Alzheimer’s disease.
Title: Applications of Recombinant Human NPEPPS/PSA
1. Recombinant Protein Production
Recombinant Human NPEPPS/PSA is commonly used in the production of recombinant proteins. It is often fused with a target protein to aid in its purification and enhance its stability. This fusion protein can then be expressed in various host systems, such as bacteria, yeast, or mammalian cells, for large-scale production.
2. Diagnostic Marker for Prostate Cancer
NPEPPS/PSA is primarily known for its role as a prostate-specific antigen (PSA). It is used as a biomarker for prostate cancer, as its levels are significantly elevated in patients with this disease. Recombinant Human NPEPPS/PSA can be used in diagnostic tests to detect and monitor prostate cancer.
3. Therapeutic Target for Alzheimer’s Disease
As mentioned earlier, NPEPPS/PSA is involved in the processing of amyloid precursor protein, which is linked to the development of Alzheimer’s disease. Therefore, this protein has been identified as a potential therapeutic target for this neurodegenerative disorder. Recombinant Human NPEPPS/PSA can be used in research studies to further understand its role in Alzheimer’s disease and to develop potential treatments.
4. Drug Screening and Development
Due to its peptidase activity, NPEPPS/PSA has been identified as a potential target for drug development. Recombinant Human NPEPPS/PSA can be used in high-throughput screening assays to identify compounds that can inhibit or modulate its activity. This can lead to the development of new drugs for various diseases, such as cancer and Alzheimer’s disease.
5. Research Tool for Peptide Analysis
Recombinant Human NPEPPS/PSA is also used as a research tool in the analysis of peptides. Its ability to cleave peptides at specific amino acid sequences makes it useful in identifying and characterizing these molecules. It can also be used in peptide mapping studies to determine the sequence of a peptide.
In conclusion, Recombinant Human NPEPPS/PSA is a versatile protein with various applications in the fields of biotechnology, medicine, and research. Its structure and activity make it an essential tool for the production of recombinant proteins, as well as a potential therapeutic target for diseases such as prostate cancer and Alzheimer’s disease. As research on this protein continues, we can expect to uncover more of its functions and potential applications in the future.
ProteoGenix catalogue number ARO-P13614. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 25.72 kDa; Tag: N-Terminal His Tag; Fragment: Gly584-Gln793; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
